StageZero Life Sciences Ltd SZLS"-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 05/14/21 EDT
0.04UNCH (UNCH)
Volume
165,000
52 week range
0.01 - 0.11

...

Loading . . .
  • Open0.04
  • Day High0.04
  • Day Low0.04
  • Prev Close0.04
  • 52 Week High0.11
  • 52 Week High Date02/19/21
  • 52 Week Low0.01
  • 52 Week Low Date07/08/20

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.04
  • Day High0.04
  • Day Low0.04
  • Prev Close0.04
  • 52 Week High0.11
  • 52 Week High Date02/19/21
  • 52 Week Low0.01
  • 52 Week Low Date07/08/20
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On StageZero Life Sciences Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
StageZero Life Sciences Ltd. is a Canada-based company focused on developing and commercializing molecular diagnostic tests for early detection of cancer. It has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. In additional, the Company offers ColonSentry product, it is a blood test to determine an individual’s current risk for having colorectal cancer. It is developing cancer testing kit Aristotle, which is a multi-cancer panel...
James Howard-Tripp
Chairman
Carl Solomon
Chief Financial Officer
Address
30-70 East Beaver Creek Rd
Richmond Hill, ON
L4B 3B2
Canada